Menu

Former US Energy Secretary to Lead AAAS

Steven Chu, the president-elect of the scientific organization, is a Nobel laureate and physicist at Stanford University.

Jan 10, 2018
Diana Kwon

WIKIMEDIA, THE ROYAL SOCIETY

The American Association for the Advancement of Science (AAAS) announced Steven Chu, a professor of physics and molecular and cellular physiology at Stanford University, as the society’s president-elect yesterday (January 9). Chu served as the Secretary of Energy during President Barack Obama’s first term in office.

“Never has there been a more important time than today for AAAS to communicate the advances in science, the methods we use to acquire this knowledge and the benefits of these discoveries to the public and our policymakers,” Chu says in his candidacy statement (via AAAS).

As Energy Secretary, Chu oversaw efforts to promote renewable energy technologies, such as solar panels and electric vehicles. “He had a substantial impact on changing research in the department, although mainly in terms of applied research,” Robert McKeown, deputy director for science at the Thomas Jefferson National Accelerator Facility, told physicsworld.com in 2013.

Chu had faced criticism, particularly from congressional Republications, who condemned, among other things, his decision to approve a $528-million government loan to Solyndra, a solar panel manufacturer that later went bankrupt. He resigned as US Energy Secretary in 2013, after four years in office.

In 1997, Chu shared the Nobel Prize in Physics with physicists Claude Cohen-Tannoudji and William Phillips for developing a technique to cool atoms and trap them with laser light.

Chu will start his three-year term with AAAS, which includes a year as president-elect, a year as president, and a year as chair of the society’s board of directors, in February. Margaret Hamburg, the current president-elect and the current foreign secretary of the National Academy of Medicine, will begin her term as president that month. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.